Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
PET imaging in multiple sclerosis.
Simvastatin Treatment of Patients With Acute Optic Neuritis
Stereotactic neurosurgery for disabling tremor in multiple sclerosis: thalamotomy or deep brain stimulation?
IS HYPERINSULINISM a precursor of multiple sclerosis?
Regulatory T-cell vaccination independent of auto-antigen.
Fumaric acid esters in psoriasis and multiple sclerosis.
Serum lipoprotein composition and vitamin D metabolite levels in clinically isolated syndromes: Results from a multi-center study.
Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation.
Early presentation of neuromyelitis optica.
Elevated moral condemnation of third-party violations in multiple sclerosis patients.
Impaired decision-making and diffusion orientational complexity in people with multiple sclerosis.
A Randomized, Double-Blind, Placebo-Controlled Trial of Duloxetine for the Treatment of Pain in Patients with Multiple Sclerosis.
Fatigue and sleep-disordered breathing in multiple sclerosis: a clinically relevant association?
Mechanisms regulating regional localization of inflammation during CNS autoimmunity.
Macrophages: A double-edged sword in experimental autoimmune encephalomyelitis.
Differential loss of KIR4.1 immunoreactivity in multiple sclerosis lesions.
Magnetic Resonance Spectroscopy: A Possible In Vivo Marker of Disease Progression for Multiple Sclerosis?
Natalizumab (BG00002) Re-Initiation of Dosing. (STRATA)
Integrin-based therapeutics: biological basis, clinical use and new drugs.
Fatigue in childhood multiple sclerosis.
Diffusion-weighted imaging using readout-segmented echo-planar imaging, parallel imaging, and two-dimensional navigator-based reacquisition in detecting acute optic neuritis.
Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later.
Sodium Benzoate, a Metabolite of Cinnamon and a Food Additive, Upregulates Ciliary Neurotrophic Factor in Astrocytes and Oligodendrocytes.
Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease.
Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation.
Pages
« first
‹ previous
…
362
363
364
365
366
367
368
369
370
…
next ›
last »